Preventing blood clots after childbirth in women at intermediate risk
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether giving a short course of a daily blood-thinning injection (enoxaparin) after childbirth can safely prevent blood clots in women at intermediate risk. If you qualify, you would receive the injection or a placebo (inactive shot) for up to 5 days while in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has just given birth (within the last 6 to 36 hours).
- You are at least 18 years old.
- Your healthcare provider has told you that you have an intermediate (moderate) risk for blood clots after childbirth.
- You have never had a blood clot before.
- You were not already receiving blood-thinning injections (like enoxaparin) during pregnancy.
- You do not have any reason that blood thinners would be unsafe for you (like severe kidney disease, bleeding problems, or a past allergic reaction to heparin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a short course of a low-dose blood thinner (heparin) to prevent dangerous blood clots in the legs or lungs after childbirth. It is for women who have certain risk factors that make clots more likely.
This study tests whether watching a short, informative video helps women who need blood thinners after giving birth. If you qualify, you'll be randomly assigned to watch the video or receive standard care.
This study tests whether a blood thinner (LMWH) can help prevent dangerous blood clots in teens with a central line and infection or inflammation in the pediatric intensive care unit (PICU). It aims to find a safer, more personalized way to use preventive treatment.
This trial is testing a new way to give blood thinners to people who have been in a serious accident. The goal is to see if adjusting the dose based on your blood levels helps prevent dangerous blood clots.
This trial tests if taking aspirin after delivery helps prevent dangerous blood clots in women with certain risk factors. It's for new mothers who have a clotting disorder, were on bed rest, or have multiple other risk factors like high weight or preeclampsia.
This trial compares two blood-thinning medicines, apixaban and enoxaparin, to see which works better at preventing dangerous blood clots after delivery. It is for women who have certain risk factors that make them more likely to get a clot.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.